CORE Biomedicine
Developing the next generation of precision medicines by going beyond genomics.
$21MSeries A
Role not disclosedUI
UTokyo Innovation Platform Co
Activity from announced rounds
Activity in this selectiongrupo-tecnologica-bd17aa86
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $21M 1 disclosed · full round size, not this investor’s share